Table 4 Proportion of clinical outcome by groups
From: Association between obesity and clinical prognosis in patients infected with SARS-CoV-2
Variables | COVID-19 patients with disease | P value | |
|---|---|---|---|
Stable-relieve n = 66, n (%) | Exacerbation n = 30, n (%) | ||
BMI stage | Â | Â | 0.001 |
  < 24 | 49 (74.2) | 10 (33.3) |  |
 24–27.9 | 13 (19.7) | 14 (46.7) |  |
  ≥ 28 | 4 (6.1) | 6 (20.0) |  |
BMI level | 22.35 ± 3.56 | 24.89 ± 3.17 | 0.001 |